Education
About Us
Working with TipRanks
Follow Us
Marksans Pharma Limited (IN:MARKSANS)
:MARKSANS
MARKSANS Stock Chart & Stats
Day’s Range― - ―
52-Week Range₹168.05 - ₹358.50
Previous CloseN/A
Volume681.00K
Average Volume (3M)544.55K
Market Cap
₹102.46B
Enterprise Value₹97.16B
Total Cash (Recent Filing)₹7.05B
Total Debt (Recent Filing)₹3.22B
Price to Earnings (P/E)26.9
Beta1.57
Next Earnings
Aug 12, 2025EPS EstimateN/A
Last Dividend Ex-Date
Aug 01, 2025Dividend Yield0.37%
Share Statistics
EPS (TTM)2.10
Shares Outstanding453,163,760
10 Day Avg. Volume1,500,578
30 Day Avg. Volume544,549
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Marksans Pharma Limited News
MARKSANS FAQ
What was Marksans Pharma Limited’s price range in the past 12 months?
Marksans Pharma Limited lowest stock price was ₹168.05 and its highest was ₹358.50 in the past 12 months.
What is Marksans Pharma Limited’s market cap?
Marksans Pharma Limited’s market cap is ₹102.46B.
When is Marksans Pharma Limited’s upcoming earnings report date?
Marksans Pharma Limited’s upcoming earnings report date is Aug 12, 2025 which is in 4 days.
How were Marksans Pharma Limited’s earnings last quarter?
Marksans Pharma Limited released its earnings results on May 19, 2025. The company reported ₹2.1 earnings per share for the quarter, beating the consensus estimate of N/A by ₹2.1.
Is Marksans Pharma Limited overvalued?
According to Wall Street analysts Marksans Pharma Limited’s price is currently Overvalued.
Does Marksans Pharma Limited pay dividends?
Marksans Pharma Limited pays a Annually dividend of ₹0.8 which represents an annual dividend yield of 0.37%. See more information on Marksans Pharma Limited dividends here
What is Marksans Pharma Limited’s EPS estimate?
Marksans Pharma Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Marksans Pharma Limited have?
Marksans Pharma Limited has 453,163,760 shares outstanding.
What happened to Marksans Pharma Limited’s price movement after its last earnings report?
Marksans Pharma Limited reported an EPS of ₹2.1 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 4.972%.
Which hedge fund is a major shareholder of Marksans Pharma Limited?
Currently, no hedge funds are holding shares in IN:MARKSANS
Company Description
Marksans Pharma Limited
Marksans Pharma Limited, together with its subsidiaries, engages in the research and development, manufacturing, marketing, distribution, and sale of generic pharmaceutical formulations worldwide. The company offers products in the analgesics, benign prostatic hyperplasia, antidiabetic, epilepsy, anti-inflammatory, hyperparathyroidism, diabetes, antacids, neurology, cardiovascular, hormonal, oncology, gastroenterology, antidiabetic, pain management, gynecology, antibiotic, antifungal, antiulceratives, vitamins, dermatology, cephalosporins, injectables, anti-allergy, antibacterial, and hypertension therapeutic areas. It also provides contract research and manufacturing services. Marksans Pharma Limited was incorporated in 1992 and is headquartered in Mumbai, India.
Technical Analysis
Aurobindo Pharma Ltd
―
Dr. Reddy's Laboratories Ltd.
―
Glenmark Pharmaceuticals Limited
―
IPCA Laboratories Limited
―
Laurus Labs Ltd.
―